Affron (R) and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Résumé
Following an application from Pharmactive Biotech Products, S.L. submitted for authorisation of ahealth claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority ofSpain, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver anopinion on the scientific substantiation of a health claim related to affron®and contributes to maintaina healthy mood. The scope of the application was proposed to fall under a health claim based onnewly developed scientific evidence. The food proposed by the applicant as the subject of the healthclaim is affron®, an aqueous saffron extract with a content of the sum of crocins and safranal typicallybetween 3.5% and 3.9%. The Panel notes that affron®is sufficiently characterised. The claimed effectproposed by the applicant is‘contributes to maintain a healthy mood’. The Panel notes that increase inpositive mood is a beneficial physiological effect for individuals with low mood or anxiety. One humanintervention study showed that consumption of affron®at a dose of 28 mg/day for 4 weeks improvesmood in a population of adults with low mood. However, the results have not been replicated in otherstudies. The information supplied by the applicant did not provide evidence for a plausible mechanismby which affron®could exert the claimed effect. The Panel concludes that the evidence is insufficientto establish a cause and effect relationship between the consumption of affron®and increase inpositive mood.
Domaines
Sciences du Vivant [q-bio]
Fichier principal
EFSA Journal - 2021 - - Affron and increase in positive mood evaluation of a health claim pursuant to Article 13 5 of.pdf (1.48 Mo)
Télécharger le fichier
| Origine | Fichiers éditeurs autorisés sur une archive ouverte |
|---|
